Maria T. De Sancho, M.D., M.Sc.

Hematology
Maria De Sancho

I have been Service Chief of the BenignHematology Service in the Division of Hematology and Medical Oncology since 2006. As a clinician, my main interest is in the care of patients with thrombotic and bleeding disorders. As a researcher who conducts clinical trials in Benign Hematology, my interest is in thrombosis and hemostasis, specifically thrombophilic disorders and women's health issues. It is my hope that through dedication to the care of each individual patient, and dedication to research that will ultimately improve that care, we will meet our overall mission of helping our patients to have a better quality of life.

Dr. DeSancho received her MD from the Autonomous University in Spain in 1983. Following a Residency in Family Practice at La Paz Hospital in Spain and a Residency in Internal Medicine at Metropolitan Hospital Center in New York, she completed fellowships in Hematology at Montefiore Medical Center from 1991-1992 and the Mount Sinai Medical Center from 1992-1993. Following this, she completed three additional fellowships at Mount Sinai in Transfusion Medicine, Medical Oncology, and Bone Marrow Transplantation. She obtained a faculty position at Columbia University as Assistant Professor of Clinical Medicine from 1997-2000, and in 2000 was appointed as Assistant Professor of Medicine and Assistant Attending Physician at Mount Sinai. Dr. DeSancho joined Weill Cornell Medical College in 2006 and is an Associate Professor of Clinical Medicine at the college and Associate Attending Physician at the New York-Presbyterian Hospital. She serves as Service Chief of the Division's Benign Hematology Service, has developed a successful clinical research program in Benign Hematology, and conducts clinical trails in Benign Hematology.

 

As a researcher, Dr. DeSancho's interest is in thrombosis and hemostasis, specifically thrombophilic disorders and women's health issues. She has participated in a number of important clinical studies. She has been Principal Investigator on many studies, including a Phase II multi center trail of a low molecular weight heparin for patients requiring bridging of anticoagulant therapy, a trial of cancer-associated thrombosis, and studies on thromboembolism in women's health. She is currently the principal investigator in a clinical trial for secondary prevention of venous thrombosis and in a clinical trial using plasma derived antithrombin in patients with hereditary antithrombin deficiency.

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [HMO]
  • AETNA [PPO]
  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicaid
  • Medicare
  • Medicare [Medicare]
  • Oscar
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Freedom]
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]

Publications

1. Sander S. Florman, Thomas M. Fishbein, Thomas Schiano, Andrew Letizia, Erin Fenelly, and Maria DeSancho. Multivisceral transplantation for portal hypertension and diffuse mesenteric thrombosis caused by protein C deficiency. Transplantation 2002, 74 (3): 406-407

2. Cynthia Gyamfi, Rachel Cohen, Maria T. DeSancho, Shreedar Gaddipati. Prophylactic dosing adjustment in pregnancy based upon measurements of anti-factor Xa levels. The Journal of Maternl-Fetal, Neonatal Medicine 2005 Nov; 18(5):329-31.

3. Niesvizky R, Martnez,Baos, Jalbrzikowski, Christos, Furst, DeSancho M; Mark;Pearse;Mazumdar;Zafar;Pekle;Rambo;Leonard;Jayabalan;Coleman; Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma, Leukemia and Lymphoma 2007

4. Maria Teresa DeSancho, MD, Nickisha Berlus, Paul J Christos, Jacob Rand, MD. Risk Factors for Clinical Manifestations in Carriers of Factor V Leiden and Prothrombin Gene Mutations.Blood Coagulation & Fibrinolysis. 21(1):11-15, January 2010

5. Karen S. Carlson MD, PhD, Maria T. DeSancho, MD, MSc. Hematological Issues in Critically ill Patients with Cancer. Crit Care Clin. 2010 Jan;26(1):107-32

6.Arnason JE, Mallik A, DE Sancho M. Peri- and postoperative haematologic management in a patient with type 2 von Willebrand disease undergoing mitral valve replacement. Haemophilia. 2010 Jun 20. [Epub ahead of print]

7. Desancho MT, Dorff T, Rand JH. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy. Blood Coagul Fibrinolysis. 2010 Jun 24. [Epub ahead of print]

 

 

Letter to Editor:

1. DeSancho MT, Lema M, Amiral J, Rand J. Frequency of antibodies against platelet factor 4 in-patients with end-stage renal disease on chronic hemodialysis. Letter to the editor. Thrombosis and Hemostasis 1996, 75 (4): 695-696

 

Book chapters:

 

1. DeSancho MT, Rand, J; Bleeding and thrombotic complications in the critically ill cancer patients in: Oncology in critical care, Critical Care Clinics of North America, July 2001, 17(3): 599-622

 

2. DeSancho, Maria, Rand, Jacob: Coagulopathic Complications of Cancer. Cancer Medicine, 6th edition 2003 (Editor: Holland J)

 

3. DeSancho, Maria, Rand, Jacob: Coagulopathic Complications of Cancer. Cancer Medicine, 7th edition 2006 (Editor: Holland J)

 

4. DeSancho, Maria, Pastores, Stephen: The Liver and Coagulation. In: Textbook of Hepatology: From Basic Science to Clinical Practice 3rd edition 2007 (Editor: Rodes J)

5. DeSancho, Maria, Rand, Jacob: Coagulopathic Complications of Cancer. Cancer Medicine, 8th edition 2009 (Editor: Holland J) (In Press)

 

6. Basciano, Paul, DeSancho, M: 5-Minutes Critical Care Consult: Coagulopathy: Lippincott 2010 (Editors: Vladimir Kvetan, MD and Jose Yunin, MD) (in Press)

 

 

 

Honors and Awards

Excellence in Licentiate's Dissertation, October 1983